PRE

Prenetics Global Ltd PRE

NasdaqSmall CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #2,647 of 2,925

Why it scores 25Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$92.39M

Quarter to Dec 31

Net income

$-37.71M

Quarter to Dec 31

Free cash flow

$-22.03M

Quarter to Dec 31

Operating margin

-48.1%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$23.94M total
Prospect Capital Advisors, LLC
$4.51MNew
JANE STREET GROUP, LLC
$4.30M+146.5%
GOLDMAN SACHS GROUP INC
$3.23M-12.8%
MILLENNIUM MANAGEMENT LLC
$2.41M-34.5%
Tenzing Global Management, LLC
$2.39M-37.5%
MARSHALL WACE, LLP
$904.9K-35.5%
NOMURA HOLDINGS INC
$805.0K-44.3%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$729.0K+15.1%
UBS Group AG
$708.2K+37.6%
Oasis Management Co Ltd.
$637.3K0.0%
XTX Topco Ltd
$582.9K-8.8%
STEVENS CAPITAL PARTNERS
$538.2K0.0%
Qube Research & Technologies Ltd
$455.2K+24.5%
MORGAN STANLEY
$448.2K+37.1%
CITADEL ADVISORS LLC
$309.5KNew
Integrated Quantitative Investments LLC
$260.1K0.0%
EntryPoint Capital, LLC
$230.5KNew
WELLS FARGO & COMPANY/MN
$191.2K-88.2%
Operose Advisors LLC
$129.1KNew
State of Wyoming
$106.4K+122.7%
LMR Partners LLP
$17.0K0.0%
Aspex Management (HK) Ltd
$15.0K-22.9%
SIMPLEX TRADING, LLC
$14.8K+117.1%
ROYAL BANK OF CANADA
$6.0K+8.1%
NINE MASTS CAPITAL Ltd
$4.4K0.0%
See all 37 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2025
EDGAR

Net Income

FY 2025
EDGAR

EPS (Diluted)

FY 2025
EDGAR

Operating Margin

FY 2025
EDGAR

ROIC

FY 2025
EDGAR

Free Cash Flow

FY 2025
EDGAR

Loading ratio trend…

PRE key financials by period

Reported revenue, net income and operating margin by fiscal year, from Prenetics Global Ltd's annual filings on SEC EDGAR.

Prenetics Global Ltd reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$92.4M$-37.7M-48.1%
FY 2024$15.9M$-46.3M—
FY 2023$21.7M$-62.7M-176.8%
FY 2022$13.2M$-190.5M—
FY 2021$12.5M$-174.0M—
FY 2020$65.2M$-1.9M-1.5%
Source: PRE filings on SEC EDGAR →

Companies similar to PRE

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

PRE insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

Congress trading in PRE

1 transaction in PRE reported by 1 member of Congress under the STOCK Act, most recent trade Jun 19, 2014. Reported transactions, not recommendations.

All Congress stock trades →

About Prenetics Global Ltd (PRE): stock profile, AI score and financials

Prenetics Global Ltd (PRE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores PRE at 24.8/100 on a composite quality score built from its SEC filings, placing it at rank #2,647 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), Prenetics Global Ltd reports quarterly revenue of $92.4M, net income of $-37.7M, an operating margin of -48.1%. Top institutional holders of PRE by reported 13-F value include Prospect Capital Advisors, JANE STREET GROUP, GOLDMAN SACHS GROUP, based on the most recent SEC filings. PRE trades on the Nasdaq exchange and files with the SEC under CIK 1876431. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PRE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Prenetics Global Ltd directly from SEC EDGAR.

SEC EDGAR: CIK 1876431 →